Citable segment mix
EW's latest SEC segment disclosure for revenue by product shows Transcatheter Aortic Valve Replacement as the largest listed segment at $1.20B (87.2% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| Transcatheter Aortic Valve Replacement | Mar 31, 2026 | $1.20B | 87.2% |
| Transcatheter Mitral and Tricuspid Therapies | Mar 31, 2026 | $175.10M | 12.8% |
Source: SEC EDGAR segment disclosures; period Mar 31, 2026.
Continue research
Follow same-sector companies and source explainers connected to the segments view.
A factual guide to revenue segment disclosures and how Aerarium Research uses them to make company business mix easier to inspect.
A factual guide to seasonal revenue patterns and comparable (same-store) sales — why year-over-year comparisons matter and what comp sales strip out.
A factual guide to deferred revenue, cash collected before revenue is earned, and why the liability can matter for recurring businesses.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
